Sari Fishman
Corporate Officer/Principal bij CAN-FITE BIOPHARMA LTD.
Vermogen: - $ op 31-05-2024
Actieve functies van Sari Fishman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CAN-FITE BIOPHARMA LTD. | Corporate Officer/Principal | 01-01-2014 | - |
| Hoofd Techniek/Wetenschap/O&O | 01-01-2004 | 01-01-2014 |
Loopbaan van Sari Fishman
Eerdere bekende functies van Sari Fishman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
OphthaliX, Inc.
 OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Sari Fishman
| Bar-Ilan University | Doctorate Degree |
Statistieken
Internationaal
| Israël | 4 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CAN-FITE BIOPHARMA LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
OphthaliX, Inc.
OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Health Technology |
- Beurs
- Insiders
- Sari Fishman
- Ervaring
